A Phase 2 Study in First Line Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma to evaluate Intratumoral MK-1454 in Combination with IV Pembrolizumab vs IV Pembrolizumab Monotherapy

Project: Research

Project Details

Effective start/end date24/02/2023/02/25


  • clinical trial
  • phase 2 study
  • monotherapy
  • treatment efficacy
  • head and neck cancer